Filer Snapshot

NANOMIX Corp SEC EDGAR Filings

SEC filings, ownership reports, and insider transactions for CIK 0001473579.

Entity Type

Company

Total Filings

307

Latest Filing

09 Apr 2025

Industry

Pharmaceutical Preparations

Save this filer page for the next filing cycle

Keep this page in your research queue, then return to compare new filings with prior context.

Save and revisit

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it

Best next steps

Start with the latest filings table, then open the strongest context page for this filer.

  • Use the filings table to verify the newest submission, form type, and report period.
  • Open the deeper context page only when this filer actually has insider or ownership signal.
Go to latest filings table Open insider trading context
Source: SEC filing REVOKED

REVOKED filed on 09 Apr 2025 for CIK 0001473579.

View Source Filing
Industry
Pharmaceutical Preparations (Office Of Life Sciences)
Business address
354 Merrimack Street, #4, Lawrence, MA, 01843
State of incorporation
DE
Fiscal year end
31 December
Former names
Boston Therapeutics, Inc. (to 05 Nov 2021), AVANYX Therapeutics, Inc. (to 23 Nov 2010)

Quick Takeaways

  • NANOMIX Corp is an SEC filer tracked under CIK 0001473579.
  • 307 filings are listed on this profile.
  • Common form coverage includes REVOKED, SC 13G/A, 8-K and more.

What Changed

  • Latest filing: REVOKED filed on 09 Apr 2025.
  • Report period: not specified in filing header.

Why This Matters

  • You can quote filing dates and form types directly from the SEC record on this page.
  • Use this profile before deeper ownership or insider analysis to confirm filing history context.

Source Evidence

Source: SEC filing REVOKED

REVOKED filed on 09 Apr 2025 for CIK 0001473579.

View Source Filing

Return Loop

Why revisit this filer page

A newly filed REVOKED can change the filing history, ownership context, or next research path for NANOMIX Corp.

Latest source-backed update
REVOKED filed 09 Apr 2025
Why come back
Revisit after a new SEC filing appears to compare the updated record with prior filings.
  • Latest filing on record: REVOKED filed 09 Apr 2025.
  • Save this filer if you want a stable place to return after the next filing cycle.
  • Open the latest filing table or ownership context to verify what changed.

Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.

Jump to save and follow actions Open latest filings table

Latest update

What changed recently for NANOMIX Corp

New fact period available

Latest financial period: Q4 2022. Open the source-backed page to inspect the fresh filing or facts context.

Update date

07 Apr 2023

Page type

Company facts

Latest period

Q4 2022

SEC-backed company facts were refreshed from filings filed on 07 Apr 2023.

Open company facts Browse recent public updates

Benchmark Context

Benchmark context for this company

NANOMIX Corp has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest financial period: Q4 2022. That gives you a fresh baseline before you compare this company with peers.

  • Latest company facts filing date: 07 Apr 2023.
  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Open company facts Browse metric rankings

Company intelligence

Research NANOMIX Corp from filings to ownership signals

Use this company page as the hub for SEC filings, fundamentals, insider activity, large-stake holders, and institutional ownership context.

Create free account to watch this company Open ownership signals

Active modules

3/5

Available company intelligence paths on this page.

Filings

307

SEC submissions provide the evidence trail.

Ownership context

1/3

Insider, large-stake, and institutional ownership lanes.

Return loop

Watch

Save the company so the next source-backed change has a clear place to bring you back.

Best-of company intelligence workflow

What changed?

Start with the latest filing and active ownership modules before opening older table rows.

Why might it matter?

Use insider, 13D/G, and 13F context to separate routine filings from ownership signals.

Where is evidence?

Keep SEC source documents one click away through filings, facts, insider reports, and Schedule 13D/G records.

What to watch next?

Save the company so watchlists can bring you back when the next filing-backed update lands.

SEC-verifiable company research path

Every company hub should answer what changed, why ownership activity might matter, where SEC evidence lives, and which filer, insider, holder, or filing page deserves the next click.

Open latest insider signals Open large-stake radar

SEC filings

Available

Latest company filings

Start with the filing timeline to verify the newest source document and report period.

Open filings table

Company facts

Available

Financial context

Use XBRL facts when ownership activity needs revenue, earnings, debt, or cash-flow context.

Open company facts

Forms 3/4/5

Available

Insider activity

Check whether directors, officers, or 10% owners are buying, selling, or filing fresh ownership changes.

Open insider activity

Schedule 13D/G

Explore

Large-stake holders

Review beneficial ownership filings for activist-style or passive large holder changes around this issuer.

Browse large-stake radar

Form 13F

Explore

Institutional holders

Compare manager filings and smart-money context when company-level ownership needs broader holders.

Browse smart-money dashboard

SEC-verifiable company hub

The strongest research path is the one that keeps source documents close: filings first, then ownership signals, insider context, and fundamentals.

Create free account to watch this company

Watchlist return triggers

Watch NANOMIX Corp when any filing-backed ownership signal appears, then jump back into the exact SEC evidence path.

new company filing insider Form 4 13D/G holder change 13F holder update

Filer Overview

NANOMIX Corp has filed 307 SEC EDGAR filings since 08 Feb 2010. Common forms include REVOKED, SC 13G/A, 8-K, NT 10-Q and more.

Pharmaceutical Preparations Insider transactions Latest 13F filings

Latest Filings

Recent SEC filings for NANOMIX Corp with direct links to document and filing folders.

REVOKED File 000-54586

REVOKED filing

Filing date
09 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87827

NNMX 13G/A

Filing date
08 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87827

NNMX 13GA

Filing date
06 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
24 Nov 2023
Reporting date
02 Nov 2023
Next action
Verify source filing
NT 10-Q File 000-54586

NOTIFICATION OF LATE FILING

Filing date
15 May 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-54586

ANNUAL REPORT

Filing date
07 Apr 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
NT 10-K File 000-54586

NOTIFICATION OF LATE FILING

Filing date
31 Mar 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87827

NNMX 13GA

Filing date
10 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
26 Jan 2023
Reporting date
19 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
25 Jan 2023
Reporting date
19 Jan 2023
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Dec 2022
Reporting date
02 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
21 Dec 2022
Reporting date
04 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Dec 2022
Reporting date
08 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
19 Dec 2022
Reporting date
14 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
19 Dec 2022
Reporting date
04 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
16 Dec 2022
Reporting date
14 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
16 Dec 2022
Reporting date
01 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
16 Dec 2022
Reporting date
26 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54586

QUARTERLY REPORT

Filing date
14 Nov 2022
Reporting date
30 Sep 2022
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
10 Nov 2022
Reporting date
21 Oct 2022
Next action
Verify source filing
4

4 filing

Filing date
21 Sep 2022
Reporting date
25 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
21 Sep 2022
Reporting date
04 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
09 Sep 2022
Reporting date
31 Aug 2022
Next action
Verify source filing
10-Q File 000-54586

QUARTERLY REPORT

Filing date
15 Aug 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
29 Jul 2022
Reporting date
22 Jul 2022
Next action
Verify source filing
424B3 File 333-265744

PROSPECTUS

Filing date
13 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-265744

EFFECT filing

Filing date
08 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
06 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-265744

AMENDMENT NO. 1 TO FORM S-1

Filing date
06 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
23 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-265744

REGISTRATION STATEMENT

Filing date
21 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54586

QUARTERLY REPORT

Filing date
17 May 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
NT 10-Q File 000-54586

NOTIFICATION OF LATE FILING

Filing date
17 May 2022
Reporting date
31 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-260298

PROSPECTUS

Filing date
17 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-260298

EFFECT filing

Filing date
12 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
10 May 2022
Reporting date
30 Mar 2022
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
10 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-260298

AMENDMENT NO. 1 TO FORM S-1

Filing date
09 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-54586

ANNUAL REPORT

Filing date
12 Apr 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
NT 10-K File 000-54586

NOTIFICATION OF LATE FILING

Filing date
29 Mar 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
24 Mar 2022
Reporting date
22 Mar 2022
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
02 Mar 2022
Reporting date
11 Jan 2022
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
01 Mar 2022
Reporting date
28 Feb 2022
Next action
Verify source filing
SC 13G File 005-87827

NNMX 13G

Filing date
07 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
17 Nov 2021
Reporting date
15 Nov 2021
Next action
Verify source filing
10-Q File 000-54586

QUARTERLY REPORT

Filing date
15 Nov 2021
Reporting date
30 Sep 2021
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
05 Nov 2021
Reporting date
05 Nov 2021
Next action
Verify source filing
8-K/A File 000-54586

AMENDMENT NO. 1 TO FORM 8-K

Filing date
05 Nov 2021
Reporting date
04 Jun 2021
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
21 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14C File 000-54586

DEFINITIVE INFORMATION STATEMENT

Filing date
20 Oct 2021
Reporting date
25 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-260298

REGISTRATION STATEMENT

Filing date
15 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54586

QUARTERLY REPORT

Filing date
05 Oct 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
10 Sep 2021
Reporting date
08 Sep 2021
Next action
Verify source filing
PRE 14C File 000-54586

PRELIMINARY INFORMATION STATEMENT

Filing date
09 Sep 2021
Reporting date
09 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-54586

AMENDMENT NO. 1 TO FORM 8-K

Filing date
27 Aug 2021
Reporting date
04 Jun 2021
Next action
Verify source filing
NT 10-Q File 000-54586

NOTIFICATION OF LATE FILING

Filing date
16 Aug 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 14F1 File 005-87827

SCHEDULE 14F-1

Filing date
23 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-405753

D filing

Filing date
09 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
29 Jun 2021
Reporting date
04 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
29 Jun 2021
Reporting date
25 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54586

QUARTERLY REPORT

Filing date
14 Jun 2021
Reporting date
31 Mar 2021
Next action
Verify source filing
8-K File 000-54586

FORM 8-K

Filing date
10 Jun 2021
Reporting date
04 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-54586

NOTIFICATION OF LATE FILING

Filing date
17 May 2021
Reporting date
31 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
12 May 2021
Reporting date
30 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-54586

ANNUAL REPORT

Filing date
23 Apr 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
NT 10-K File 000-54586

NOTIFICATION OF LATE FILING

Filing date
05 Apr 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
02 Feb 2021
Reporting date
26 Jan 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54586

QUARTERLY REPORT

Filing date
28 Dec 2020
Reporting date
30 Sep 2020
Next action
Verify source filing
10-Q File 000-54586

QUARTERLY REPORT

Filing date
17 Dec 2020
Reporting date
30 Jun 2020
Next action
Verify source filing
10-Q File 000-54586

QUARTERLY REPORT

Filing date
30 Nov 2020
Reporting date
31 Mar 2020
Next action
Verify source filing
10-K File 000-54586

ANNUAL REPORT

Filing date
08 Jun 2020
Reporting date
31 Dec 2019
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
15 May 2020
Reporting date
15 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K/A File 000-54586

FORM NT 10-K

Filing date
15 May 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-195341

POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-8

Filing date
11 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-185355

POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8

Filing date
11 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-177171

POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8

Filing date
11 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
14 Apr 2020
Reporting date
14 Apr 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 000-54586

NOTIFICATION OF LATE FILING

Filing date
30 Mar 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
23 Jan 2020
Reporting date
10 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
10 Jan 2020
Reporting date
12 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
06 Dec 2019
Reporting date
02 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54586

QUARTERLY REPORT

Filing date
19 Nov 2019
Reporting date
30 Sep 2019
Next action
Verify source filing
NT 10-Q File 000-54586

NOTIFICATION OF LATE FILING

Filing date
15 Nov 2019
Reporting date
30 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

CURRENT REPORT

Filing date
25 Sep 2019
Reporting date
24 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54586

QUARTERLY REPORT

Filing date
19 Aug 2019
Reporting date
30 Jun 2019
Next action
Verify source filing
NT 10-Q File 000-54586

NOTIFICATION OF LATE FILING

Filing date
14 Aug 2019
Reporting date
30 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-54586

NT 10-Q

Filing date
15 May 2019
Reporting date
31 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 000-54586

NT 10-K

Filing date
01 Apr 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

8-K

Filing date
06 Dec 2018
Reporting date
30 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

8-K

Filing date
02 Jul 2018
Reporting date
26 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

8-K

Filing date
14 Jun 2018
Reporting date
12 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

8-K

Filing date
01 Jun 2018
Reporting date
01 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-54586

8-K/A

Filing date
30 Apr 2018
Reporting date
12 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
07 Mar 2018
Reporting date
12 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
13 Feb 2018
Reporting date
14 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

8-K

Filing date
12 Feb 2018
Reporting date
12 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-54586

8-K

Filing date
12 Feb 2018
Reporting date
14 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14C File 000-54586

DEF 14C

Filing date
09 Feb 2018
Reporting date
09 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14C File 000-54586

PRE 14C

Filing date
22 Jan 2018
Reporting date
11 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-54586

8-K/A

Filing date
01 Nov 2017
Reporting date
14 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

8-K

Filing date
22 Aug 2017
Reporting date
14 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

8-K

Filing date
19 Jun 2017
Reporting date
16 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
10 May 2017
Reporting date
12 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

8-K

Filing date
02 May 2017
Reporting date
26 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
01 Dec 2016
Reporting date
23 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
15 Nov 2016
Reporting date
15 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54586

BOSTON THERAPEUTICS, INC. 10-Q

Filing date
10 Nov 2016
Reporting date
30 Sep 2016
Next action
Verify source filing
SC 13D/A File 005-87827

SC 13D/A

Filing date
13 Oct 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D/A File 021-269587

D/A filing

Filing date
20 Sep 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
20 Sep 2016
Reporting date
15 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
14 Sep 2016
Reporting date
11 Sep 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-269587

D filing

Filing date
25 Aug 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54586

BOSTON THERAPEUTICS, INC. 10-Q

Filing date
15 Aug 2016
Reporting date
30 Jun 2016
Next action
Verify source filing
RW File 333-198198

BOSTON THERAPEUTICS RW

Filing date
13 Jul 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-54586

BOSTON THERAPEUTICS, INC. 8-K/A

Filing date
06 Jul 2016
Reporting date
24 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS 8-K

Filing date
10 Jun 2016
Reporting date
08 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
12 May 2016
Reporting date
24 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54586

BOSTON THERAPEUTICS, INC. 10-Q

Filing date
11 May 2016
Reporting date
31 Mar 2016
Next action
Verify source filing
10-K File 000-54586

BOSTON THERAPEUTICS, INC. 10-K

Filing date
30 Mar 2016
Reporting date
31 Dec 2015
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
22 Mar 2016
Reporting date
16 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87827

BOSTON THERAPEUTICS, INC. SCHEDULE 13D/A

Filing date
15 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-54586

BOSTON THERAPEUTICS, INC. 8-K/A

Filing date
02 Mar 2016
Reporting date
24 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC.

Filing date
19 Jan 2016
Reporting date
19 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS 8-K

Filing date
10 Dec 2015
Reporting date
10 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54586

BOSTON THERAPEUTICS, INC. 10-Q

Filing date
20 Nov 2015
Reporting date
30 Sep 2015
Next action
Verify source filing
NT 10-Q File 000-54586

BOSTON THERAPEUTICS NT 10-Q

Filing date
16 Nov 2015
Reporting date
16 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
12 Nov 2015
Reporting date
12 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-54586

BOSTON THERAPEUTICS 8-K/A

Filing date
30 Oct 2015
Reporting date
24 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPUTICS, INC. 8-K

Filing date
02 Oct 2015
Reporting date
24 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
28 Sep 2015
Reporting date
28 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87827

SC 13G/A

Filing date
24 Sep 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
04 Sep 2015
Reporting date
04 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54586

BOSTON THERAPEUTICS, INC. 10-Q

Filing date
13 Aug 2015
Reporting date
30 Jun 2015
Next action
Verify source filing
SC 13G File 005-87827

SCHEDULE 13G

Filing date
20 Jul 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
16 Jul 2015
Reporting date
10 Jul 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Jun 2015
Reporting date
15 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54586

BOSTON THERAPEUTICS, INC. 10-Q

Filing date
20 May 2015
Reporting date
31 Mar 2015
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 May 2015
Reporting date
14 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-54586

BOSTON THERAPEUTICS, INC. NT 10-Q

Filing date
15 May 2015
Reporting date
31 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-198198

BOSTON THERAPEUTICS, INC. S-1/A (NO. 5)

Filing date
11 May 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-198198

BOSTON THERAPEUTICS, INC. S-1/A

Filing date
28 Apr 2015
Reporting date
Not listed
Next action
Verify source filing
SC 13D File 005-87827

BOSTON THERAPEUTICS, INC. SC13D

Filing date
01 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-54586

BOSTON THERAPEUTICS, INC. 10-K

Filing date
27 Mar 2015
Reporting date
31 Dec 2014
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
23 Mar 2015
Reporting date
18 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Mar 2015
Reporting date
25 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
19 Mar 2015
Reporting date
13 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Mar 2015
Reporting date
10 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
16 Mar 2015
Reporting date
25 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
11 Mar 2015
Reporting date
10 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Mar 2015
Reporting date
09 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-87827

BOSTON THERAPEUTICS, INC. SC 13D

Filing date
20 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Feb 2015
Reporting date
17 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Feb 2015
Reporting date
12 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-198198

BOSTON THERAPEUTICS, INC. S-1/A

Filing date
11 Feb 2015
Reporting date
Not listed
Next action
Verify source filing
S-1/A File 333-198198

BOSTON THERAPEUTICS, INC. S-1/A

Filing date
09 Feb 2015
Reporting date
Not listed
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Feb 2015
Reporting date
02 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Jan 2015
Reporting date
27 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Jan 2015
Reporting date
23 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Jan 2015
Reporting date
20 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
20 Jan 2015
Reporting date
15 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jan 2015
Reporting date
15 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jan 2015
Reporting date
09 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Jan 2015
Reporting date
07 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Jan 2015
Reporting date
05 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Jan 2015
Reporting date
31 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
31 Dec 2014
Reporting date
30 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-198198

BOSTON THERAPEUTICS, INC. S-1/A

Filing date
13 Nov 2014
Reporting date
Not listed
Next action
Verify source filing
10-Q File 000-54586

BOSTON THERAPEUTICS, INC.

Filing date
07 Nov 2014
Reporting date
30 Sep 2014
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
14 Oct 2014
Reporting date
14 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
01 Oct 2014
Reporting date
01 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
22 Sep 2014
Reporting date
22 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-198198

BOSTON THERAPEUTICS, INC.

Filing date
15 Aug 2014
Reporting date
Not listed
Next action
Verify source filing
10-Q File 000-54586

BOSTON THERAPEUTICS, INC. 10-Q

Filing date
08 Aug 2014
Reporting date
30 Jun 2014
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
03 Jul 2014
Reporting date
03 Jul 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
21 May 2014
Reporting date
21 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54586

BOSTON THERAPEUTICS, INC. 10-Q

Filing date
13 May 2014
Reporting date
31 Mar 2014
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Apr 2014
Reporting date
12 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
30 Apr 2014
Reporting date
03 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Apr 2014
Reporting date
08 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
21 Apr 2014
Reporting date
25 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-195341

BOSTON THERAPEUTICS, INC. S-8

Filing date
17 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-192344

BOSTON THERAPEUTICS, INC. 424(B)(3)

Filing date
10 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-192344

EFFECT filing

Filing date
08 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
08 Apr 2014
Reporting date
12 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Apr 2014
Reporting date
08 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Apr 2014
Reporting date
08 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Apr 2014
Reporting date
12 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Apr 2014
Reporting date
12 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Apr 2014
Reporting date
12 Feb 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
04 Apr 2014
Reporting date
03 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
04 Apr 2014
Reporting date
03 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-192344

BOSTON THERAPEUTICS, INC. POS AM

Filing date
26 Mar 2014
Reporting date
Not listed
Next action
Verify source filing
10-K File 000-54586

BOSTON THERAPEUTICS, INC. 10-K

Filing date
14 Mar 2014
Reporting date
31 Dec 2013
Next action
Verify source filing
EFFECT File 333-192344

EFFECT filing

Filing date
11 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
10 Feb 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Jan 2014
Reporting date
13 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-87827

BOSTON THERAPEUTICS, INC. SC 13D

Filing date
29 Jan 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
29 Jan 2014
Reporting date
08 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-192344

BOSTON THERAPEUTICS S-1/A

Filing date
15 Jan 2014
Reporting date
Not listed
Next action
Verify source filing
S-1/A File 333-192344

BOSTON THERAPEUTICS S-1/A

Filing date
07 Jan 2014
Reporting date
Not listed
Next action
Verify source filing
S-1/A File 333-192344

BOSTON THERAPEUTICS S-1/A

Filing date
31 Dec 2013
Reporting date
Not listed
Next action
Verify source filing
S-1/A File 333-192344

BOSTON THERAPEUTICS S-1/A

Filing date
17 Dec 2013
Reporting date
Not listed
Next action
Verify source filing
AW File 333-192344

BOSTON THERAPEUTICS, INC. AW

Filing date
17 Dec 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-184047

BOSTON THERAPEUTICS S-1/A

Filing date
12 Dec 2013
Reporting date
Not listed
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS 8-K

Filing date
04 Dec 2013
Reporting date
04 Dec 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
22 Nov 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-192344

BOSTON THERAPEUTICS, INC. S-1

Filing date
14 Nov 2013
Reporting date
Not listed
Next action
Verify source filing
10-Q File 000-54586

BOSTON THERAPEUTICS, INC. 10-Q

Filing date
13 Nov 2013
Reporting date
30 Sep 2013
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
15 Oct 2013
Reporting date
15 Oct 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
04 Oct 2013
Reporting date
30 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
16 Sep 2013
Reporting date
16 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
06 Sep 2013
Reporting date
06 Sep 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54586

BOSTON THERAPEUTICS, INC. 10-Q

Filing date
09 Aug 2013
Reporting date
30 Jun 2013
Next action
Verify source filing
D File 021-200922

D filing

Filing date
07 Aug 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
29 Jul 2013
Reporting date
23 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14C File 000-54586

BOSTON THERAPEUTICS DEF 14C

Filing date
23 Jul 2013
Reporting date
23 Jul 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
PRER14C File 000-54586

BOSTON THERAPEUTICS PRE 14C

Filing date
09 Jul 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
27 Jun 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRER14C File 000-54586

BOSTON THERAPEUTICS PRE 14C

Filing date
27 Jun 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
26 Jun 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14C File 000-54586

BOSTON THERAPEUTICS SCHEDULE 14C

Filing date
20 Jun 2013
Reporting date
20 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
06 Jun 2013
Reporting date
31 May 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54586

BOSTON THERAPEUTICS, INC. 10-Q

Filing date
15 May 2013
Reporting date
31 Mar 2013
Next action
Verify source filing
10-K File 000-54586

BOSTON THERAPEUTICS, INC. 10-K

Filing date
04 Apr 2013
Reporting date
31 Dec 2012
Next action
Verify source filing
NT 10-K File 000-54586

FORM 12B-25

Filing date
01 Apr 2013
Reporting date
31 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-184047

EFFECT filing

Filing date
15 Mar 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-184047

BOSTON THERAPEUTICS, INC. POS AM

Filing date
14 Mar 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
5

PRIMARY DOCUMENT

Filing date
13 Feb 2013
Reporting date
31 Dec 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-185355

BOSTON THERAPEUTICS, INC. S-8

Filing date
07 Dec 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54586

BOSTON THERAPEUTICS 10-Q

Filing date
14 Nov 2012
Reporting date
30 Sep 2012
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
14 Nov 2012
Reporting date
13 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-184047

BOSTON THERAPEUTICS, INC 424(B)(3)

Filing date
14 Nov 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS 8-K

Filing date
13 Nov 2012
Reporting date
08 Nov 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-184047

EFFECT filing

Filing date
15 Oct 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
10 Oct 2012
Reporting date
10 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-184047

BOSTON THERAPEUTICS, INC. S-1/A

Filing date
05 Oct 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS 8-K

Filing date
04 Oct 2012
Reporting date
04 Oct 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54586

BOSTON THERAPEUTICS, INC. 10-Q

Filing date
14 Aug 2012
Reporting date
30 Jun 2012
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
14 Jun 2012
Reporting date
14 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Jun 2012
Reporting date
08 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS 8-K

Filing date
07 Jun 2012
Reporting date
07 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54586

BOSTON THERAPEUTICS, INC. 10-Q

Filing date
18 May 2012
Reporting date
31 Mar 2012
Next action
Verify source filing
NT 10-Q File 000-54586

BOSTON THERAPEUTICS, INC. NT 10-Q

Filing date
15 May 2012
Reporting date
31 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
27 Apr 2012
Reporting date
27 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
18 Apr 2012
Reporting date
18 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8K

Filing date
10 Apr 2012
Reporting date
10 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-54586

BOSTON THERAPEUTICS, INC. 10-K

Filing date
30 Mar 2012
Reporting date
31 Dec 2011
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Mar 2012
Reporting date
23 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Mar 2012
Reporting date
20 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
22 Mar 2012
Reporting date
20 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 000-54586

BOSTON THERAPEUTICS, INC. 10-Q/A

Filing date
21 Mar 2012
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54586

BOSTON THERAPEUTICS, INC. 8-K

Filing date
02 Mar 2012
Reporting date
28 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
25 Jan 2012
Reporting date
25 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
25 Jan 2012
Reporting date
25 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
25 Jan 2012
Reporting date
25 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
25 Jan 2012
Reporting date
25 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
25 Jan 2012
Reporting date
25 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
25 Jan 2012
Reporting date
25 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12G File 000-54586

BOSTON THERAPEUTICS, INC. 8-A12G

Filing date
25 Jan 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-164785

BOSTON THERAPEUTICS, INC. 8-K

Filing date
24 Jan 2012
Reporting date
24 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-164785

BOSTON THERAPEUTICS, INC. 8-K

Filing date
29 Dec 2011
Reporting date
08 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-164785

BOSTON THERAPEUTICS, INC. 8-K

Filing date
22 Dec 2011
Reporting date
20 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
RW File 333-164785

BOSTON THERAPEUTICS, INC. RW

Filing date
18 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 333-164785

BOSTON THERAPEUTICS, INC. 10-Q

Filing date
14 Nov 2011
Reporting date
30 Sep 2011
Next action
Verify source filing
8-K File 333-164785

BOSTON THERAPEUTICS, INC. 8-K

Filing date
11 Oct 2011
Reporting date
11 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-177171

BOSTON THERAPEUTICS, INC. S-8

Filing date
04 Oct 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 333-164785

CT ORDER filing

Filing date
19 Sep 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 333-164785

BOSTON THERAPEUTICS, INC. 10-Q/A

Filing date
09 Sep 2011
Reporting date
30 Jun 2011
Next action
Verify source filing
10-Q File 333-164785

BOSTON THERAPEUTICS, INC. 10-Q

Filing date
15 Aug 2011
Reporting date
30 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-164785

BOSTON THERAPEUTICS, INC. 8-K

Filing date
04 Aug 2011
Reporting date
04 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-162273

D filing

Filing date
05 Jul 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-164785

BOSTON THERAPEUTICS, INC. 8-K

Filing date
30 Jun 2011
Reporting date
24 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-164785

BOSTON THERAPEUTICS, INC. 8-K

Filing date
22 Jun 2011
Reporting date
21 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 333-164785

BOSTON THERAPEUTICS, INC. 10-Q

Filing date
16 May 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-164785

BOSTON THERAPEUTICS, INC. POS AM

Filing date
15 Apr 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 333-164785

2010 ANNUAL REPORT - AMENDMENT NO. 1

Filing date
01 Apr 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 333-164785

NT 10-K filing

Filing date
01 Apr 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 333-164785

2010 ANNUAL REPORT

Filing date
01 Apr 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-164785

AMENDMENT TO CURRENT REPORT - NOVEMBER 18, 2010

Filing date
27 Jan 2011
Reporting date
10 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-164785

CURRENT REPORT

Filing date
30 Nov 2010
Reporting date
24 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-164785

CURRENT REPORT - NOVEMBER 23, 2010

Filing date
24 Nov 2010
Reporting date
23 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 333-164785

SEPTEMBER 30, 2010 QUARTERLY REPORT

Filing date
23 Nov 2010
Reporting date
30 Sep 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-164785

8-K NOVEMBER 10, 2010

Filing date
18 Nov 2010
Reporting date
10 Nov 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 333-164785

EXTENSION OF TIME TO FILE FORM 10-Q

Filing date
15 Nov 2010
Reporting date
30 Sep 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-164785

CURRENT REPORT - OCTOBER 28 2010

Filing date
29 Oct 2010
Reporting date
28 Oct 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-164785

EFFECT filing

Filing date
15 Oct 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
13 Oct 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-164785

AVANYX THERAPEUTICS, INC. S-1/A

Filing date
08 Oct 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
20 Sep 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-164785

AVANYX THERAPEUTICS, INC. S-1/A

Filing date
20 Sep 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
12 Aug 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
20 Jul 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-164785

AVANYX THERAPEUTICS, INC. S-1/A

Filing date
24 Jun 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
08 Mar 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-164785

S-1 filing

Filing date
08 Feb 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing

About this filer

NANOMIX Corp files with the SEC under CIK 0001473579. This page aggregates EDGAR filings and related ownership activity.

Industry: Pharmaceutical Preparations.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .